![](https://www.wur.nl/upload_mm/8/f/d/72ebee87-adaa-45a3-bc1a-bba68930be77_Flagship_glucose_me_6b5609fd_1200x800.jpg)
News
Surfix develops a test method for corona diagnosis
Surfix, located at Wageningen Campus, together with their Dutch partners Lionix International and Qurin Diagnostics and supported by public-private partnership Photon Delta develops a test method for corona diagnosis and immunity detection.
The aim is to have SARS-CoV-2 testing devices in doctors’ offices, which yield reliable test results within 5 minutes. The device will be built around a photonic biochip using LioniX International’s proven silicon nitride based integrated optics technology (TriPleX™). The ultimate goal is to make a test for the masses- a widely available, disposable test, which can be read out in a hand-held PoC device and will only cost a few euros.
See the Surfix website for recent developments and background information about the new test method.